All ProductsDisplaying Products Alphabetically by Name (S)
Cat. No. | Product Name / Activity |
---|---|
5568 | S 18886 |
Potent thromboxane A2 (TP) antagonist | |
5714 | S 2101 |
LSD1 inhibitor | |
3518 | S 24795 |
α7 nAChR partial agonist | |
5577 | S4 |
High affinity and selective CA IX and CA XII inhibitor | |
8050 | SA-15-P New |
Dual inhibitor of LAG3 interaction with both MHCII and FGL1 | |
4951 | SA 4503 dihydrochloride |
Selective σ1 receptor agonist | |
4366 | SAG |
Potent Smoothened receptor agonist; activates the Hedgehog signaling pathway | |
5282 | SAG 21k |
Hedgehog signaling activator; brain penetrant and orally bioavailable | |
6390 | SAG dihydrochloride |
Dihydrochloride salt of SAG; Smo receptor agonist | |
4652 | SAHA |
Class I and II HDAC inhibitor | |
7970 | SAHA-FITC New |
Fluorescent HDAC1/2 probe; suitable for use in TR-FRET and FP assays | |
6477 | SAHM1 |
Notch pathway inhibitor; prevents Notch complex assembly | |
6239 | SAK 3 |
Potent CaV3.1 and 3.3 activator; orally bioavailable | |
1974 | SANT-1 |
Inhibitor of hedgehog (Hh) signaling; antagonizes smoothened activity | |
5831 | SAR 7334 |
Potent TRPC6 inhibitor | |
1264 | SB 202190 |
Potent, selective inhibitor of p38 MAPK | |
1202 | SB 203580 |
Selective inhibitor of p38 MAPK | |
1402 | SB 203580 hydrochloride |
Selective inhibitor of p38 MAPK; water-soluble | |
1372 | SB 204741 |
Potent, selective 5-HT2B antagonist | |
4962 | SB 204990 |
ATP citrate lyase (ACLY) inhibitor | |
0921 | SB 205607 dihydrobromide |
Selective, high affinity non-peptide δ1 agonist | |
1661 | SB 206553 hydrochloride |
Potent and selective 5-HT2B and 5-HT2C antagonist; orally active | |
1242 | SB 216641 hydrochloride |
Selective h5-HT1B antagonist | |
1616 | SB 216763 |
Potent, selective GSK-3 inhibitor | |
2560 | SB 218078 |
Chk1 inhibitor | |
1393 | SB 222200 |
Potent, selective non-peptide NK3 antagonist. Brain penetrant | |
1221 | SB 224289 hydrochloride |
Selective 5-HT1B antagonist | |
2725 | SB 225002 |
Potent and selective CXCR2 antagonist | |
1962 | SB 239063 |
Potent, selective p38 MAPK inhibitor; orally active | |
8010 | SB 24011 New |
Inhibitor of STING-TRIM29 interaction; increases cellular STING levels | |
2901 | SB 242084 |
Selective 5-HT2C antagonist; brain penetrant | |
1961 | SB 258585 hydrochloride |
Potent, selective 5-HT6 antagonist | |
2726 | SB 258719 hydrochloride |
Selective 5-HT7 antagonist | |
2724 | SB 265610 |
Potent CXCR2 antagonist | |
1612 | SB 269970 hydrochloride |
Potent and selective 5-HT7 antagonist; brain penetrant | |
3368 | SB 271046 hydrochloride |
Selective 5-HT6 antagonist; orally active | |
4207 | SB 277011A dihydrochloride |
Selective D3 antagonist | |
6860 | SB 290157 trifluoroacetate |
Potent C3a receptor antagonist | |
4213 | SB 297006 |
Potent and selective CCR3 antagonist | |
3650 | SB 328437 |
Potent and selective CCR3 antagonist | |
5671 | SB 332235 |
Potent CXCR2 antagonist | |
1960 | SB 334867 |
Selective non-peptide OX1 antagonist | |
1615 | SB 366791 |
Potent and selective TRPV1 competitive antagonist | |
3189 | SB 399885 hydrochloride |
Potent and selective 5-HT6 antagonist | |
6088 | SB 3CT |
High affinity and selective MMP2 inhibitor | |
6881 | SB 4 |
Potent BMP4 agonist | |
1963 | SB 408124 |
Selective non-peptide OX1 antagonist | |
1617 | SB 415286 |
Potent, selective GSK-3 inhibitor | |
TB1614-GMP | SB 431542 |
SB 431542 synthesized to cGMP guidelines | |
3263 | SB 505124 |
Selective inhibitor of TGF-βRI, ALK4 and ALK7 | |
3211 | SB 525334 |
Selective inhibitor of TGF-βRI | |
2650 | SB 590885 |
Potent B-Raf inhibitor | |
3573 | SB 612111 hydrochloride |
Selective NOP antagonist | |
4673 | SB 674042 |
Potent and selective non-peptide OX1 antagonist | |
3188 | SB 699551 |
Selective 5-ht5a antagonist | |
5040 | SB 706504 |
p38 MAPK inhibitor | |
4630 | SB 747651A dihydrochloride |
Potent MSK1 inhibitor; also inhibits other AGC group kinases | |
4118 | SB 772077B dihydrochloride |
Potent Rho-kinase inhibitor; vasodilator | |
4963 | SC 144 hydrochloride |
gp130 inhibitor; blocks cytokine-triggered gp130 signaling | |
1206 | SC 19220 |
Selective EP1 receptor antagonist | |
4189 | SC 26196 |
Selective fatty acid desaturase 2 inhibitor | |
2791 | SC 51322 |
Potent EP1 receptor antagonist | |
1550 | SC 560 |
Cyclooxygenase-1 (COX-1) inhibitor | |
3919 | SC 236 |
Selective cyclooxygenase-2 (COX-2) inhibitor | |
4635 | SC 79 |
Akt activator | |
1400 | SCH 202676 hydrobromide |
Inhibitor of ligand binding to G-protein-coupled receptors | |
3240 | SCH 221510 |
Potent and selective NOP agonist | |
0925 | SCH 23390 hydrochloride |
Selective D1-like antagonist; also 5-HT2C agonist and Kir3 channel blocker | |
1690 | SCH 28080 |
H+,K+-ATPase inhibitor | |
5815 | SCH 336 |
Highly potent and selective CB2 inverse agonist | |
2299 | SCH 39166 hydrobromide |
High affinity D1-like antagonist | |
2463 | SCH 442416 |
Very selective, high affinity A2A antagonist | |
0984 | SCH 50911 |
Selective and competitive GABAB antagonist; orally bioavailable | |
2270 | SCH 58261 |
Potent, highly selective A2A antagonist | |
1592 | SCH 79797 dihydrochloride |
Potent, selective non-peptide PAR1 antagonist | |
3528 | SCIO 469 hydrochloride |
Selective p38 MAPK inhibitor | |
7900 | SCOTfluor 510 Fmoc-Dapa-OH New |
Fmoc protected fluorescent amino acid for use in solid-phase peptide synthesis to prepare PAINT imaging probes | |
7446 | SCOTfluor 510, fluoro |
Amine-reactive fluorescent probe precursor | |
7447 | SCOTfluor glucose probe 510 |
Fluorescent glucose probe | |
7448 | SCOTfluor lactic acid probe 510 |
Fluorescent lactic acid probe | |
5342 | SCR7 pyrazine |
Enhances HDR efficiency | |
3035 | SD 1008 |
JAK2/STAT3 signaling pathway inhibitor | |
3269 | SD 208 |
Potent ATP-competitive TGF-βRI inhibitor | |
4775 | SD 2590 hydrochloride |
Potent MMP inhibitor | |
1250 | SDZ 220-581 |
Competitive NMDA antagonist | |
2394 | SDZ NKT 343 |
Highly selective human NK1 antagonist | |
2465 | SDZ WAG 994 |
Potent and selective A1 agonist | |
6164 | SEA 0400 |
Potent Na+/Ca2+ exchanger (NCX) inhibitor | |
6979 | SEN 177 |
Potent glutaminyl cyclase inhibitor; disrupts binding of SIRP-α to CD47 | |
6990 | SET 2 |
Selective TRPV2 antagonist | |
2284 | SEW 2871 |
Cell-permeable, selective S1P1 receptor agonist | |
3898 | SF 11 |
NPY Y2 receptor antagonist | |
5020 | SF 1670 |
PTPN2 and PTEN inhibitor | |
4541 | SGC 0946 |
Highly potent and selective DOT1L inhibitor; cell permeable | |
6825 | SGC 3027 |
Potent and selective PRMT7 inhibitor | |
6838 | SGC 3027N |
Negative control for SGC 3027 (Cat. No. 6825) | |
7182 | SGC 6870 |
Potent and selective PRMT6 allosteric inhibitor | |
7184 | SGC 6870N |
Negative control for SGC 6870 (Cat. No. 7182) | |
5367 | SGC 707 |
Potent and selective allosteric inhibitor of PRMT3 | |
6528 | SGC AAK1 1 |
AAK1 and BMP2K inhibitor; activates Wnt signaling | |
6529 | SGC AAK1 1N |
Negative control for SGC AAK1 1 (Cat.No. 6528) | |
7450 | SGC CK2-1 |
Potent CK2A2 and CK2A1 inhibitor; also inhibits DYRK2 | |
6564 | SGC GAK 1 |
High affinity cyclin G associated kinase (GAK) inhibitor | |
7460 | SGC SMARCA-BRDVIII |
Potent and selective SMARCA2/4 and PB1(bromo 5)-selective SWI/SNF bromodomain inhibitor | |
4889 | SGC-CBP30 |
Potent CBP/p300 BRD inhibitor | |
5356 | SGX 523 |
Selective and potent c-MET kinase inhibitor | |
4510 | SHA 68 |
Selective Neuropeptide S receptor antagonist | |
6998 | SHIN 1 |
Potent SHMT inhibitor | |
3420 | SHU 9119 |
MC3 and MC4 antagonist; MC5 partial agonist | |
5964 | SI-2 hydrochloride |
Steroid receptor coactivator 3 (SRC-3) inhibitor | |
3625 | SID 26681509 |
Cathepsin L inhibitor | |
3440 | SID 7969543 |
Selective steroidogenic factor-1 (SF-1, NR5A1) inhibitor | |
7432 | SIM1 |
Potent and selective trivalent BET Bromodomain Degrader (PROTAC®) | |
0756 | SIN-1 chloride |
Water-soluble NO donor | |
7969 | SIS17 |
Selective HDAC11 inhibitor | |
5291 | SIS3 |
Selective Smad3 inhibitor; inhibits TGF-βR1 signaling | |
7675 | SJ 1008030 |
Selective JAK2 Degrader (PROTAC®) | |
7542 | SJ 1008066 |
MAGE-A11 inhibitor; disrupts MAGE-A11:PCF11 interaction | |
7727 | SJ 10542 |
Potent and selective JAK2/3 Degrader (PROTAC®) | |
7721 | SJ 11646 |
Potent and selective LCK Degrader (PROTAC®) | |
7720 | SJ 6986 |
Molecular glue; induces degradation of GSPT1/2 | |
7463 | SJF 0628 |
Potent BRAF Degrader (PROTAC® | |
7464 | SJF 0661 |
Negative control for SJF 0628 (Cat. No. 7463) | |
7261 | SJF 1521 |
Selective EGFR PROTAC® Degrader | |
7262 | SJF 1528 |
Potent EGFR PROTAC® Degrader; also degrades HER2 | |
7266 | SJF 8240 |
c-MET PROTAC®; also degrades exon-14-deleted c-MET | |
7268 | SJFα |
Potent and selective p38α PROTAC® | |
7267 | SJFδ |
Potent and selective p38δ PROTAC® | |
6187 | SK 216 |
Plasminogen activator inhibitor-1 (PAI-1) inhibitor | |
7583 | SK 575 |
Potent PARP1 Degrader (PROTAC®) | |
7588 | SK 575-NEG |
Negative control for SK 575 (Cat. No. 7583) | |
1079 | (+)-SK&F 10047 hydrochloride |
σ1 selective agonist | |
6398 | SKA 121 |
Positive allosteric modulator of KCa3.1 (IK) channels | |
3670 | SKA 31 |
KCa3.1 (IK) and KCa2 (SK) channel activator | |
0922 | SKF 38393 hydrobromide |
Selective D1-like agonist | |
1447 | SKF 81297 hydrobromide |
D1 agonist | |
1586 | SKF 83566 hydrobromide |
Potent and selective D1-like antagonist; also inhibits adenylyl cyclase 2 | |
2075 | SKF 83822 hydrobromide |
Selective D1-like agonist | |
3866 | SKF 86466 hydrochloride |
Potent and selective α2 antagonist | |
1081 | SKF 89976A hydrochloride |
Potent GAT-1 inhibitor; brain penetrant | |
1147 | SKF 96365 hydrochloride |
TRPC channel inhibitor; also inhibits store-operated Ca2+ entry | |
0379 | SKF 97541 |
Highly potent GABAB agonist; also GABAA-ρ antagonist | |
2097 | SKI II |
Selective non-lipid inhibitor of sphingosine kinase | |
2250 | SL 0101-1 |
Selective ribosomal S6 kinase (RSK) inhibitor | |
1969 | SL 327 |
Selective inhibitor of MEK1 and MEK2; brain penetrant | |
3010 | SLIGKV-NH2 |
PAR2 receptor agonist | |
1468 | SLIGRL-NH2 |
PAR2-activating peptide | |
6281 | SLM 6031434 hydrochloride |
Selective sphingosine kinase 2 (Sphk2) inhibitor | |
8112 | SLU-PP-332 |
Potent pan-ERR agonist | |
6245 | SM 16 |
Potent TGF-βRI inhibitor; orally bioavailable | |
5445 | SM 324405 |
Potent TLR7 agonist | |
0751 | SM-21 maleate |
Presynaptic cholinergic modulator | |
5314 | SMBA 1 |
High affinity and selective activator of Bax | |
4297 | SMER 28 |
Positive regulator of autophagy | |
4375 | SMER 3 |
Selective inhibitor of E3 ubiquitin ligase | |
7192 | SMIP 004 |
SKP2 (S-phase kinase-associated protein 2) inhibitor; upregulates p27 and arrests cell cycle in G1 phase | |
2684 | SN 38 |
DNA topoisomerase I inhibitor; antitumor | |
2184 | SN-6 |
Selective Na+/Ca2+ exchange inhibitor (reverse mode) | |
0598 | SNAP |
A stable analog of endogenous S-nitroso compounds | |
1561 | (S)-SNAP 5114 |
GABA uptake inhibitor | |
3347 | SNAP 94847 hydrochloride |
Potent and selective MCH1 antagonist | |
1529 | SNC 162 |
Potent, selective non-peptide δ agonist | |
0764 | SNC 80 |
Highly selective non-peptide δ agonist | |
7120 | SNIPER(ER)-87 |
Potent and selective ERα Degrader (SNIPER) | |
0603 | SNOG |
NO carrier. Breaks down to release NO | |
4075 | SNS 032 |
Cdk inhibitor; potently inhibits cdk2, cdk7 and cdk9 | |
7322 | SP 10 |
Highly potent inhibitor of SARS-CoV Spike (S) protein and ACE2 interaction | |
5309 | SP 100030 |
NF-κB and AP-1 dual inhibitor | |
5332 | SP 141 |
High affinity MDM2 inhibitor | |
1496 | SP 600125 |
Selective JNK inhibitor | |
7498 | SPOP-i-6lc |
SPOP E3 ubiquitin ligase inhibitor | |
5391 | SPP 86 |
Potent RET inhibitor | |
6597 | SPRi 3 |
Potent sepiapterin reductase (SPR) inhibitor; attenuates proliferation of CD4+ T cells | |
6055 | SPT Imidazopyridine 1 |
Potent serine palmitoyl transferase inhibitor | |
1435 | SQ 22536 |
Adenylyl cyclase inhibitor | |
5868 | SR 0987 |
T cell-specific RORγ (RORγt) agonist | |
6038 | SR 10067 |
Selective Rev-Erbα/β agonist; anxiolytic | |
4874 | SR 1078 |
RORα/γ agonist | |
3411 | SR 11237 |
Pan RXR agonist | |
2476 | SR 11302 |
AP-1 inhibitor; antitumor agent | |
2969 | SR 12813 |
Pregnane X receptor agonist | |
5431 | SR 13800 |
Potent MCT1 inhibitor | |
4012 | SR 140333 |
Potent NK1 antagonist | |
0923 | SR 141716A |
Selective CB1 inverse agonist | |
2309 | SR 142948 |
Highly potent NTS receptor antagonist | |
4424 | SR 16584 |
Selective α3β4 nAChR antagonist | |
6383 | SR 16832 |
Dual site PPARγ inhibitor | |
2022 | SR 202 |
Selective PPARγ antagonist; antidiabetic and antiobesity agent | |
4869 | SR 2211 |
Selective RORγ inverse agonist | |
2190 | SR 27897 |
Potent and selective CCK1 antagonist | |
5044 | SR 3576 |
Highly potent and selective JNK3 inhibitor | |
3667 | SR 3677 dihydrochloride |
Potent, selective Rho-kinase (ROCK) inhibitor | |
3721 | SR 48692 |
Selective non-peptide NTS1 antagonist | |
2310 | SR 49059 |
Selective, orally active vasopressin V1A receptor antagonist | |
1205 | SR 57227 hydrochloride |
Potent and selective 5-HT3 agonist | |
3986 | SR 58611A hydrochloride |
β3 agonist; displays anxiolytic and antidepressant effects | |
1511 | SR 59230A hydrochloride |
Potent and selective β3 antagonist | |
5626 | SR 7826 |
Potent and selective LIMK inhibitor; antitumor | |
4463 | SR 8278 |
Rev-Erbα antagonist | |
5855 | SR 9009 |
Rev-Erbα/β agonist | |
5854 | SR 9238 |
Potent and selective LXR inverse agonist | |
6138 | SR 9243 |
Selective LXR inverse agonist | |
1262 | SR 95531 hydrobromide |
Competitive and selective GABAA antagonist | |
7558 | SRT 1720 |
Selective SIRT1 activator; induces autophagy and mitochondrial biogenesis | |
5253 | SSM 3 trifluoroacetate |
Potent furin inhibitor | |
3297 | SSR 146977 hydrochloride |
Potent and selective NK3 antagonist | |
6195 | SSR 149415 |
Potent and selective vasopressin V1B antagonist | |
5559 | SSR 180711 hydrochloride |
Selective α7 nAChR partial agonist | |
2506 | SSR 69071 |
Potent, orally active human leukocyte elastase inhibitor | |
7554 | SSYA10-001 |
Potent coronavirus helicase inhibitor; also inhibits human papillomavirus E6 | |
6271 | ST 034307 |
Adenylyl cyclase 1 (AC1) inhibitor; analgesic and active in vivo | |
6775 | ST 045849 |
O-GlcNAc transferase (OGT) inhibitor | |
4509 | STF 083010 |
Inhibits IRE1α endonuclease activity | |
4484 | STF 31 |
NAMPT inhibitor; also GLUT1 inhibitor | |
8054 | STING Degrader N-Me-SP23 |
Negative control for STING Degrader SP23 (Cat. No. 8053) | |
8053 | STING Degrader SP23 |
Selective STING Degrader (PROTAC®) | |
7741 | STING agonist C53 |
Pan-polymorph STING agonist | |
1551 | STO-609 acetate |
Selective CaM kinase kinase inhibitor | |
5570 | STOCK2S 26016 |
Lysine deficient protein kinase (WNK) signaling inhibitor | |
7341 | STX 64 |
Potent steroid sulfatase inhibitor; also inhibits carbonic anhydrase II | |
3304 | SU 16f |
Potent and selective PDGFRβ inhibitor | |
3607 | SU 3327 |
Selective JNK inhibitor | |
3300 | SU 5402 |
Potent FGFR and VEGFR inhibitor | |
3037 | SU 5416 |
VEGFR inhibitor. Also inhibits KIT, RET, MET and FLT3 | |
6475 | SU 6656 |
Potent ATP-competitive Src family kinase inhibitor; also AMPK inhibitor; cell permeable | |
3335 | SU 6668 |
PDGFR, VEGFR and FGFR inhibitor | |
2550 | SUN-B 8155 |
Non-peptide calcitonin agonist | |
5759 | SW 033291 |
High affinity 15-PGDH inhibitor; promotes hematopoiesis and hepatocyte proliferation | |
5076 | SZL P1-41 |
Selective Skp2 inhibitor; suppresses E3 ligase activity | |
0246 | Saclofen |
Selective GABAB antagonist | |
5772 | Sacubitril calcium |
Membrane metallo-endopeptidase (neprilysin) inhibitor prodrug; orally bioavailable | |
3657 | Sal 003 |
Cell-permeable inhibitor of eIF2α dephosphorylation | |
0634 | Salbutamol hemisulfate |
β2-adrenoceptor agonist | |
4712 | Salmeterol xinafoate |
Long-acting β2 agonist; bronchodilator | |
2347 | Salubrinal |
Selective inhibitor of eIF2α dephosphorylation | |
5611 | Salvinorin B |
Activator of κ-opioid DREADD (KORD) | |
2302 | Sanguinarine chloride |
Inhibitor of protein phosphatase 2C (PP2C) | |
7191 | Santacruzamate A |
Highly potent and selective HDAC2 inhibitor | |
4418 | Saquinavir mesylate |
HIV protease inhibitor | |
7189 | Saracatinib |
Potent and selective Src tyrosine kinase family inhibitor; anticancer; antiviral; orally bioavailable | |
3739 | Sarpogrelate hydrochloride |
Selective 5-HT2A antagonist | |
6507 | Saxagliptin hydrochloride |
High affinity DPP-IV inhibitor; active in vivo | |
2736 | Sazetidine A dihydrochloride |
α4β2 nAChR ligand; may act as an agonist or a desensitizer | |
1414 | Scopolamine hydrobromide |
Non-selective muscarinic antagonist | |
7449 | Se-NADA |
Orange fluorescent benzoselenadiazole D-amino acid (FDAA) for imaging bacteria; also photosensitizer | |
2849 | SecinH3 |
Sec7-specific GEF inhibitor; selective for cytohesin family | |
1918 | Secretin (human) |
Gastrointestinal peptide | |
1919 | Secretin (rat) |
Gastrointestinal peptide | |
7760 | Selinexor |
Selective exportin 1 (XPO1/CRM1) inhibitor | |
7696 | Selpercatinib |
Potent and selective RET inhibitor | |
7555 | SenTraGor™ |
Reagent for staining and detection of lipofuscin in senescent cells | |
4875 | Senexin A |
Cdk8 inhibitor | |
1068 | Senktide |
Tachykinin NK3 agonist | |
5553 | Sephin 1 |
Inhibitor of the regulatory subunit PPP1R15A of protein phosphatase 1 | |
0226 | D-Serine |
Potentiator of NMDA recepors; acts at glycine site | |
3547 | Serotonin hydrochloride |
Endogenous 5-HT receptor agonist | |
2395 | Sertraline hydrochloride |
5-HT reuptake inhibitor | |
7544 | SiRA 2 New |
Fluorogen for SiRA light-up aptamer. Application: confocal microscopy, SRM (including STED) | |
3784 | Sildenafil citrate |
Potent PDE5 inhibitor; orally active | |
6663 | Silodosin |
Selective α1A antagonist | |
1965 | Simvastatin |
HMG-CoA reductase inhibitor | |
4044 | Sipatrigine |
NaV blocker; neuroprotective | |
5457 | SirReal 2 |
Selective inhibitor of SIRT2 | |
3521 | Sirtinol |
Selective sirtuin family deacetylase inhibitor | |
6816 | Sitagliptin phosphate |
Potent and selective DPP IV inhibitor | |
3535 | Sivelestat sodium salt |
Selective leukocyte elastase inhibitor | |
6424 | Sodium Cromoglicate |
Promotes ESCs/iPSCs differentiation into pancreatic endocrine islet cells | |
3850 | Sodium butyrate |
Histone deacetylase inhibitor | |
2821 | Sodium orthovanadate |
Protein tyrosine phosphatase inhibitor | |
1157 | Somatostatin |
Influences growth hormone release | |
1165 | Somatostatin 1-28 |
sst agonist | |
4185 | Sonepiprazole |
Selective D4 antagonist | |
7826 | Sonidegib |
Potent Smoothened receptor antagonist | |
6814 | Sorafenib |
Potent Raf-1 inhibitor; also inhibits VEGFR-2, VEGFR-3, PDGFR-β, Flt-3 and cKIT | |
0952 | Sotalol hydrochloride |
β antagonist | |
5594 | Spadin |
Potent K2P2.1 (TREK-1) channel blocker | |
5197 | Spautin 1 |
USP10 and USP13 inhibitor; inhibits autophagy | |
0958 | Spermine tetrahydrochloride |
Modulator at polyamine site | |
6090 | Spexin |
Potent GAL2/3 agonist; exhibits anxiolytic effects in vivo | |
1370 | Sphingosine-1-phosphate |
Endogenous agonist at S1P1-5 | |
2968 | Spironolactone |
Mineralocorticoid receptor antagonist | |
6364 | Squarunkin A hydrochloride |
UNC119 chaperone-cargo interaction inhibitor; disrupts Src activation | |
3642 | Src I1 |
Dual site Src kinase inhibitor | |
2798 | Stattic |
Selective STAT3 inhibitor | |
1285 | Staurosporine |
Non-selective protein kinase inhibitor | |
TB1285-RMU | Staurosporine |
Staurosporine synthesized to Ancillary Material Grade | |
7086 | StemRegenin 1 |
Aryl hydrocarbon receptor (AhR) antagonist; promotes HSC expansion and engraftment | |
1621 | Streptozocin |
DNA alkylator; antitumor and induces diabetes | |
1608 | Stressin I |
CRF1 agonist | |
1156 | Substance P |
Sensory neuropeptide; inflammatory mediator | |
1178 | [Sar9,Met(O2)11]-Substance P |
Potent and selective NK1 agonist | |
4935 | Sulfasalazine |
Inhibitor of NF-κB activation; also inhibits SXC and folate transporter 1 | |
4943 | Sulfidefluor 7 AM |
H2S fluorescent probe | |
7302 | Sulfo-NHS-LC-Biotin |
Amine reactive biotinylation reagent, cell impermeable | |
0162 | S-Sulfo-L-cysteine sodium salt |
Group I mGlu agonist | |
5146 | Sulforhodamine 101 |
Red fluorescent dye; selective astrocyte marker | |
0894 | (RS)-(±)-Sulpiride |
Standard selective D2-like antagonist | |
0895 | (S)-(-)-Sulpiride |
Standard selective D2-like antagonist | |
2773 | Sumanirole maleate |
Selective D2 agonist | |
3586 | Sumatriptan succinate |
5-HT1A, 5-HT1B and 5-HT1D agonist | |
3768 | Sunitinib malate |
Potent VEGFR, PDGFRβ and KIT inhibitor | |
1472 | Suramin hexasodium salt New |
Non-selective P2 antagonist | |
6634 | Surfen |
Heparin sulfate antagonist | |
3208 | Swainsonine |
Inhibitor of α-mannosidase II | |
5118 | SynaptoRedTM C2 |
Fluorescent dye. Used for: synaptic vesicles staining. Application: fluorescence microscopy |
Tocris Products by Catalog Number
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800